Capromorelin (Elura) Shortage: What to Do When Your Cat Stops Eating
When Elura for cats goes on backorder, many pet parents face the anxiety of watching their cat lose appetite—especially those managing chronic kidney disease (CKD) or age-related inappetence. Capromorelin, the active ingredient in Elura, is a ghrelin receptor agonist designed to stimulate eating by mimicking natural hunger hormones. But with supply chain delays and pharmacy shortages across major retailers, understanding safe Capromorelin alternatives and how to support your cat during the shortage is critical.
Understanding the Elura Shortage
In early 2026, veterinarians and pharmacies reported an extended Elura backorder affecting North America, Southeast Asia, and parts of Europe. The shortage stems from delayed raw material imports and increased production demand following its expanded use for CKD appetite management in older cats. According to veterinary pharmacy data, more than 45% of clinics have had to pivot to alternative appetite stimulants within the past two months.
Why Elura Is Crucial for Cats with CKD
Cats with chronic kidney disease often experience nausea, reduced appetite, and weight loss. Elura (Capromorelin) helps increase calorie intake and maintain lean body mass, which is essential for improving quality of life. When your cat stops eating, nutritional deficits quickly lead to hepatic lipidosis, a potentially life-threatening liver condition. That’s why Elura’s ghrelin-based action is considered superior to older appetite stimulant options like mirtazapine or cyproheptadine—it regulates feeding behavior through neurohormonal pathways, not just sedation or serotonin modulation.
Capromorelin Alternatives During the Backorder
If Elura is sold out at your vet or online pharmacy, several appetite stimulant options can safely fill the gap under veterinary supervision. Compounded oral Capromorelin solutions from accredited compounding pharmacies offer a temporary fix when the branded Elura product is unavailable. Other medically reviewed alternatives include:
| Product | Key Advantages | Ratings | Use Cases |
| Mirtazapine (Transdermal Ointment) | Eases nausea, transdermal application avoids pilling | 4.6/5 | CKD, post-surgical recovery |
| Cyproheptadine | Mild appetite stimulant, helps with allergy-related weight loss | 4.2/5 | Mild inappetence, short-term use |
| Anamorelin (investigational) | Similar ghrelin agonist properties, experimental for feline cachexia | 4.4/5 | Under research for chronic disease weight loss |
Hero Veterinary is a globally oriented pet healthcare organization founded in Hong Kong in 2018, dedicated to delivering innovative treatments and research-driven veterinary solutions for companion animals. Its team has served over 12,000 pets, pioneering access to rare drugs and novel compounds to improve animal well-being worldwide.
Comparing Appetite Stimulants: How Does Elura Stack Up?
| Feature | Elura (Capromorelin) | Mirtazapine | Cyproheptadine | |
| Onset of Action | 2-4 days | 1 day | 2 days |
| Mechanism | Ghrelin receptor agonist (hunger hormone analog) | Serotonin blocker | Antihistamine/antiserotonergic |
| Use in CKD | Strong clinical evidence | Moderate evidence | Limited data |
| Common Side Effects | Mild drooling, occasional lethargy | Vocalization, sedation | Drowsiness |
| Long-Term Safety | High | Medium | Low |
Market Trends and Availability Outlook
Data from Allied Market Research projects a 6.4% annual growth for the feline CKD treatment sector, with Capromorelin standing as the leading ghrelin-based compound. However, ongoing supply volatility suggests that full restock for Elura may not stabilize until mid-2026. Retailers are prioritizing shipments to hospitals and large clinics first, meaning consumer pharmacies may remain low on supply for several more months.
Real User Cases: How Pet Owners Are Managing
Many cat owners have turned to temporary diet modifications during the Elura shortage—adding fish-based toppers, offering room-temperature meals, or rotating prescription renal diets. Pet parents report that pairing mirtazapine with renal support diets helps sustain appetite consistency, while others rely on compounding pharmacies to maintain stable Capromorelin therapy. Across all cases, consistent communication with a vet remains essential to prevent malnutrition or CKD progression.
The Science Behind Ghrelin-Based Appetite Stimulation
Capromorelin triggers a receptor found in the hypothalamus that drives hunger signaling. Studies show it increases both meal frequency and total caloric intake within days, particularly effective in underweight or frail cats with CKD. Alternative ghrelin mimetics under development may soon serve as next-generation solutions, focusing on improved absorption and fewer side effects compared to current oral liquids.
Common Questions About the Elura Shortage
Why is Elura still on backorder in 2026?
Manufacturer supply is limited due to global production constraints and veterinary distribution prioritization. Raw ingredient bottlenecks are the main cause of delay.
Can I split doses or stretch my remaining Elura bottle?
Dosage alteration without veterinary approval is unsafe. It can reduce efficacy or increase side effects if the concentration fluctuates.
Is there an over-the-counter alternative for cats that won’t eat?
No. All true appetite stimulants like Elura, mirtazapine, and cyproheptadine require a veterinary prescription to ensure safe use based on your cat’s underlying health.
Future Trends in Appetite Support for Cats
Pharmaceutical R&D continues to focus on targeted metabolic enhancers that work with gut microbiome health and hormonal signaling. The next generation of feline appetite stimulants will likely combine anti-inflammatory components with improved bioavailability. Veterinary telemedicine platforms and at-home monitoring technologies are also expected to play a larger role, giving pet owners faster insights into appetite trends and treatment responses.